The Medicines Company’s Orbactiv Approved on Solid SOLO Data
Great news came in The Medicines Company ’s ( MDCO ) way when the FDA approved the company’s antibiotic Orbactiv. Orbactiv was approved in the U.S. for the treatment of adults suffering from acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible designated gram-positive bacteria including methicillin-resistant staphylococcus aureus (MRSA). […]